Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 73
Filtrar
2.
Trends Mol Med ; 27(3): 231-247, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-33218944

RESUMEN

There is increasing evidence that extracellular vesicles (EVs) mediate the paracrine effects of stem cells. Although EVs have several attractive characteristics, they also raise issues related to delivery. For patients with cardiac disease that require a surgical procedure, direct intramyocardial (IM) administration of EVs is straightforward but its efficacy may be limited by fast wash-out, hence the interest of incorporating EVs into a controlled release polymer to optimize their residence time. For patients without surgical indication, the intravenous (IV) route is attractive because of its lack of invasiveness; however, whole-body distribution limits the fraction of EVs that reach the heart, hence the likely benefits of EV engineering to increase EV homing to the target tissue.


Asunto(s)
Materiales Biocompatibles , Anomalías Cardiovasculares/terapia , Sistemas de Liberación de Medicamentos/métodos , Vesículas Extracelulares , Bioingeniería , Humanos , Células Madre Mesenquimatosas/metabolismo , Células Madre/metabolismo
3.
Tissue Cell ; 64: 101330, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32473704

RESUMEN

BACKGROUND: Mesenchymal stem cells (MSCs) are multipotent, genomic stable, self-renewable, and culturally expandable adult stem cells. MSCs facilitate tissue development, maintenance and repair, and produce secretory factors that support engraftment and trophic functions, marking them an attractive option in cell therapy, regenerative medicine and tissue engineering. METHOD: In this review, we summarize the recent researches regarding the isolation and characterization of MSCs, therapeutic applications and advanced engineering techniques. We also discuss the advantages and limitations that remain to be overcome for MSCs based therapy. RESULTS: It has been demonstrated that MSCs are able to modulate endogenous tissue and immune cells. Preclinical studies and early phase clinical trials have shown their great potential for tissue engineering of bone, cartilage, marrow stroma, muscle, fat, and other connective tissues. CONCLUSIONS: MSC-based therapy show considerable promise to rebuild damaged or diseased tissues, which could be a promising therapeutic method for regeneration medicine.


Asunto(s)
Células Madre Mesenquimatosas , Medicina Regenerativa/métodos , Células Madre Adultas , Huesos/patología , Anomalías Cardiovasculares/terapia , Diferenciación Celular , Humanos , Inflamación/terapia , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/inmunología , Células Madre Mesenquimatosas/metabolismo , Ingeniería de Tejidos
4.
Pediatrics ; 145(2)2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31964759

RESUMEN

This set of recommendations is designed to assist the pediatrician in caring for children with Williams syndrome (WS) who were diagnosed by using clinical features and with chromosome 7 microdeletion confirmed by fluorescence in situ hybridization, chromosome microarray, or multiplex ligation-dependent probe amplification. The recommendations in this report reflect review of the current literature, including previously peer-reviewed and published management suggestions for WS, as well as the consensus of physicians and psychologists with expertise in the care of individuals with WS. These general recommendations for the syndrome do not replace individualized medical assessment and treatment.


Asunto(s)
Síndrome de Williams/complicaciones , Adolescente , Adulto , Factores de Edad , Anomalías Cardiovasculares/etiología , Anomalías Cardiovasculares/terapia , Niño , Preescolar , Estreñimiento/etiología , Estreñimiento/terapia , Atención Dental para Niños/métodos , Facies , Femenino , Trastornos de la Audición/etiología , Humanos , Hipercalcemia/complicaciones , Hipercalcemia/diagnóstico , Hipercalcemia/terapia , Hipotiroidismo/etiología , Lactante , Masculino , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Sistema Nervioso/terapia , Fotograbar , Examen Físico , Problema de Conducta/psicología , Transición a la Atención de Adultos , Sistema Urinario/anomalías , Síndrome de Williams/genética , Síndrome de Williams/terapia , Adulto Joven
5.
Semin Fetal Neonatal Med ; 24(6): 101030, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31563413

RESUMEN

The transition from fetal to neonatal life is a dramatic and complex process involving extensive physiologic changes, which are most obvious at the time of birth. Individuals who care for newly born infants must monitor the progress of the transition and be prepared to intervene when necessary. In the majority of births, this transition occurs without a requirement for any significant assistance. If newborns require assistance, the majority of the time respiratory support is all that is required. In some instances, however, there are circulatory emergencies that need to be rapidly identified or there may be dire consequences including death in the delivery room. This chapter will review various pathologies that are circulatory emergencies, and discuss how to assess them. We will also review new technologies which may help providers better understand the circulatory status or hemodynamic changes in the delivery room including heart rate, cardiac output, cerebral oxygenation and echocardiography.


Asunto(s)
Anomalías Cardiovasculares , Sistema Cardiovascular/fisiopatología , Enfermedades del Recién Nacido , Manejo de Atención al Paciente/métodos , Anomalías Cardiovasculares/diagnóstico , Anomalías Cardiovasculares/etiología , Anomalías Cardiovasculares/fisiopatología , Anomalías Cardiovasculares/terapia , Urgencias Médicas/clasificación , Humanos , Recién Nacido , Enfermedades del Recién Nacido/fisiopatología , Enfermedades del Recién Nacido/terapia , Neonatología/métodos , Ultrasonografía Prenatal/métodos
6.
Vet Clin North Am Equine Pract ; 35(1): 139-157, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30871834

RESUMEN

Pericardial, myocardial, and great vessel diseases are relatively rare in horses. The clinical signs are often nonspecific and vague, or related to the underlying cause. Physical examination usually reveals tachycardia, fever, venous distension or jugular pulsation, a weak or bounding arterial pulse, ventral edema, and abnormal cardiac auscultation such as arrhythmia, murmur, or muffled heart sounds. The prognosis depends on the underlying cause and the disease progression, and ranges from full recovery to poor prognosis for survival. This article focuses on the etiology, diagnosis, prognosis, and treatment of pericarditis, pericardial mass lesions, myocarditis, cardiomyopathy, and great vessel aneurysm or rupture.


Asunto(s)
Anomalías Cardiovasculares/veterinaria , Cardiopatías/veterinaria , Enfermedades de los Caballos/diagnóstico , Animales , Aorta/anomalías , Cardiomiopatías/diagnóstico , Cardiomiopatías/etiología , Cardiomiopatías/terapia , Cardiomiopatías/veterinaria , Anomalías Cardiovasculares/diagnóstico , Anomalías Cardiovasculares/etiología , Anomalías Cardiovasculares/terapia , Cardiopatías/diagnóstico , Cardiopatías/etiología , Cardiopatías/terapia , Enfermedades de los Caballos/etiología , Enfermedades de los Caballos/terapia , Caballos , Miocarditis/diagnóstico , Miocarditis/etiología , Miocarditis/terapia , Miocarditis/veterinaria , Pericarditis/diagnóstico , Pericarditis/etiología , Pericarditis/terapia , Pericarditis/veterinaria , Pronóstico
7.
Biomed Res Int ; 2019: 3081029, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30809536

RESUMEN

There is strong evidence that considerable health benefits can be achieved even with small amounts of physical activity. However, getting people to exercise regularly is a major challenge not least in the elderly population. This study investigated the feasibility and physiological health effects of a pragmatic 15-week exercise programme for sedentary elderly. In a single-blind randomised controlled trial, 45 sedentary 60-83-year-olds (25 women, 20 men) were randomly assigned (2:1 ratio) to a training group (TG, n=30) or a control group (CG, n=15). The training in TG consisted of a combination of exercise modalities (i.e., strength, aerobic fitness, stability, and flexibility training) performed once a week as supervised group-based training and a weekly home-based training for 15 weeks. Feasibility outcomes were exercise intensity, adherence, and adverse events. The primary outcome was change in aerobic fitness (VO2max/kg). Adherence was high (81%) for the supervised exercise and low (0%) for the home-based exercise. No acute injuries occurred in TG, but 4 subjects (13%) reported considerable joint pain related to training. Average heart rate (HR) during the supervised training was 104±12 beats/min (69.3±8.0%HRmax), with 3.9±7.3% of training time >90%HRmax. Intention-to-treat analyses revealed no between-group differences for aerobic fitness (P=0.790) or any secondary cardiovascular outcomes at 15-week follow-up (resting HR or blood pressure; P>0.05). Compared to CG, bodyweight (-2.3 kg, 95% CI -4.0 to -7.0; P=0.006), total fat mass (-2.0 kg, 95% CI -3.5 to -0.5; P=0.01), and total fat percentage (-1.6%, 95% CI -2.8 to -0.3; P=0.01) decreased in TG. The group-based supervised training had high adherence and moderate exercise intensity, whereas the home-based training was not feasible in this study population. This exercise programme performed once a week did not improve aerobic fitness. Thus, supervised training with more vigorous intensity control appears advisable. Clinical Study registration number is H-15016951.


Asunto(s)
Anomalías Cardiovasculares/terapia , Terapia por Ejercicio , Conducta Sedentaria , Anciano , Anciano de 80 o más Años , Presión Sanguínea , Anomalías Cardiovasculares/fisiopatología , Anomalías Cardiovasculares/prevención & control , Ejercicio Físico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Método Simple Ciego , Factores de Tiempo
8.
Vasc Endovascular Surg ; 53(2): 154-156, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30305009

RESUMEN

We report a simple endovascular repair for symptomatic aberrant right subclavian artery (ARSA) in an 11-year-old girl. She had undergone tracheostomy due to hypoxic encephalopathy after cardiac surgery and suffered from dyspnea. Computed tomography revealed tracheal stenosis caused by a vascular ring made with an ARSA and the right common carotid artery. Transcatheter ARSA embolization using an Amplatzer vascular plug and coils was performed. Symptoms improved within a few days after this intervention and no complications such as upper extremity ischemia were encountered. Computed tomography showed the ARSA around the trachea had reduced in size and tracheal stenosis was improved.


Asunto(s)
Anomalías Cardiovasculares/terapia , Embolización Terapéutica/métodos , Procedimientos Endovasculares/métodos , Arteria Subclavia/anomalías , Estenosis Traqueal/terapia , Traqueostomía/efectos adversos , Anomalías Cardiovasculares/complicaciones , Anomalías Cardiovasculares/diagnóstico por imagen , Anomalías Cardiovasculares/fisiopatología , Niño , Angiografía por Tomografía Computarizada , Disnea/etiología , Disnea/terapia , Femenino , Humanos , Arteria Subclavia/diagnóstico por imagen , Arteria Subclavia/fisiopatología , Estenosis Traqueal/diagnóstico por imagen , Estenosis Traqueal/etiología , Estenosis Traqueal/fisiopatología , Resultado del Tratamiento
11.
Mov Disord ; 33(3): 421-430, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29465787

RESUMEN

BACKGROUND: The objective of this study was to investigate 24-month of effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms in Parkinson's disease (PD). METHODS: In this prospective, observational, multicenter, international study including 67 PD patients undergoing bilateral STN-DBS, we examined the Non-motor Symptom Scale, Non-Motor Symptoms Questionnaire, Parkinson's Disease Questionnaire-8, Scales for Outcomes in Parkinson's Disease-motor examination, -activities of daily living, and -complications, and levodopa-equivalent daily dose preoperatively and at 5 and 24-month of follow-up. After checking distribution normality, longitudinal outcome changes were investigated with Friedman tests or repeated-measures analysis of variance and Bonferroni correction for multiple comparisons using multiple tests. Post hoc, Wilcoxon signed rank t tests were computed to compare visits. The strength of clinical responses was analyzed using effect size. Explorative Spearman correlations of change scores from baseline to 24-month follow-up were calculated for all outcomes. RESULTS: The Non-motor Symptom Scale and all other outcome parameters significantly improved from baseline to the 5-month follow-up. From 5 to 24-month, partial decrements in these gains were found. Nonetheless, comparing baseline with 24-month follow-up, significant improvements were observed for the Non-motor Symptom Scale (small effect), Scales for Outcomes in PD-motor examination showed a moderate effect, and Scales for Outcomes in Parkinson's Disease-complications and levodopa-equivalent daily dose showed large effects. Non-motor Symptom Scale change scores from baseline to 24-month follow-up correlated significantly with Parkinson's Disease Questionnaire-8, Scales for Outcomes in Parkinson's Disease-activities of daily living, and -motor complications change scores. CONCLUSIONS: This study provides evidence of beneficial effects of bilateral STN-DBS on nonmotor symptoms at 24-month follow-up. The extent of nonmotor symptom improvement was directly proportionate to improvements in quality of life, activities of daily living, and motor complications. This study underlines the importance of nonmotor symptoms for holistic assessments of DBS outcomes. © 2018 International Parkinson and Movement Disorder Society.


Asunto(s)
Estimulación Encefálica Profunda/métodos , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/terapia , Núcleo Subtalámico/fisiología , Resultado del Tratamiento , Anciano , Antiparkinsonianos/uso terapéutico , Anomalías Cardiovasculares/etiología , Anomalías Cardiovasculares/terapia , Femenino , Humanos , Cooperación Internacional , Levodopa/uso terapéutico , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/fisiopatología , Enfermedad de Parkinson/psicología , Calidad de Vida , Disfunciones Sexuales Fisiológicas/etiología , Disfunciones Sexuales Fisiológicas/terapia , Trastornos del Sueño-Vigilia/etiología , Trastornos del Sueño-Vigilia/terapia , Encuestas y Cuestionarios
13.
J Neurol ; 264(6): 1247-1253, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28550476

RESUMEN

Obstructive sleep apnea (OSA) is a known-risk factor for cardiovascular diseases. There are indications that treatment with continuous positive airway pressure (CPAP) reduces the risk of new cardiovascular events. In this study, we analyzed the incidence of cardiovascular events in patients with OSA and compared for the impact of CPAP therapy. All polysomnographies performed in 2009 and 2010 were selected with an AHI ≥5 and patients older than 18 years. These 1110 patients were approached with a questionnaire about cardiovascular events and CPAP treatment. Finally, 554 patients were included in analyses. CPAP treatment was based on compliance (level 1 treatment) and extended with residual respiratory events (level 2 treatment). OSA was set as AHI ≥5 and classified in mild (AHI 5-15), moderate (AHI 15-30) and severe (AHI ≥30) OSA. 50 cardiovascular events occurred in 44 patients during follow-up (mean follow-up time 5.9 years) in 554 patients. The events were significantly higher in patients with increasing classification of OSA-severity (p = 0.016). A first-ever cardiovascular event did not differ significantly between mild, moderate and severe OSA. Untreated CPAP patients had significantly more cardiovascular events as compared to treated patients with a hazard ratio of 2.66 partially adjusted for age, AHI and smoking. There was no significant contribution of other cardiovascular risk factors. Patients with OSA with an indication for CPAP treatment have more cardiovascular events when untreated compared to treated patients. This indicates that treatment of OSA by CPAP can reduce the risk for cardiovascular events.


Asunto(s)
Anomalías Cardiovasculares/complicaciones , Presión de las Vías Aéreas Positiva Contínua/métodos , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/terapia , Accidente Cerebrovascular/complicaciones , Adulto , Anciano , Anomalías Cardiovasculares/epidemiología , Anomalías Cardiovasculares/terapia , Electromiografía , Femenino , Humanos , Incidencia , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Polisomnografía , Apnea Obstructiva del Sueño/epidemiología , Estadísticas no Paramétricas , Accidente Cerebrovascular/epidemiología , Encuestas y Cuestionarios
15.
Am J Med Genet A ; 170(10): 2617-31, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27302097

RESUMEN

Myhre syndrome is a rare, distinctive syndrome due to specific gain-of-function mutations in SMAD4. The characteristic phenotype includes short stature, dysmorphic facial features, hearing loss, laryngotracheal anomalies, arthropathy, radiographic defects, intellectual disability, and a more recently appreciated spectrum of cardiovascular defects with a striking fibroproliferative response to surgical intervention. We report four newly described patients with typical features of Myhre syndrome who had (i) a mildly narrow descending aorta and restrictive cardiomyopathy; (ii) recurrent pericardial and pleural effusions; (iii) a large persistent ductus arteriosus with juxtaductal aortic coarctation; and (iv) restrictive pericardial disease requiring pericardiectomy. Additional information is provided about a fifth previously reported patient with fatal pericardial disease. A literature review of the cardiovascular features of Myhre syndrome was performed on 54 total patients, all with a SMAD4 mutation. Seventy percent had a cardiovascular abnormality including congenital heart defects (63%), pericardial disease (17%), restrictive cardiomyopathy (9%), and systemic hypertension (15%). Pericarditis and restrictive cardiomyopathy are associated with high mortality (three patients each among 10 deaths); one patient with restrictive cardiomyopathy also had epicarditis. Cardiomyopathy and pericardial abnormalities distinguish Myhre syndrome from other disorders caused by mutations in the TGF-ß signaling cascade (Marfan, Loeys-Dietz, or Shprintzen-Goldberg syndromes). We hypothesize that the expanded spectrum of cardiovascular abnormalities relates to the ability of the SMAD4 protein to integrate diverse signaling pathways, including canonical TGF-ß, BMP, and Activin signaling. The co-occurrence of congenital and acquired phenotypes demonstrates that the gene product of SMAD4 is required for both developmental and postnatal cardiovascular homeostasis. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Anomalías Cardiovasculares/diagnóstico , Anomalías Cardiovasculares/genética , Criptorquidismo/diagnóstico , Criptorquidismo/genética , Trastornos del Crecimiento/diagnóstico , Trastornos del Crecimiento/genética , Deformidades Congénitas de la Mano/diagnóstico , Deformidades Congénitas de la Mano/genética , Discapacidad Intelectual/diagnóstico , Discapacidad Intelectual/genética , Mutación , Fenotipo , Proteína Smad4/genética , Adolescente , Adulto , Anomalías Cardiovasculares/terapia , Niño , Criptorquidismo/terapia , Ecocardiografía , Exones , Facies , Femenino , Estudios de Asociación Genética , Trastornos del Crecimiento/terapia , Deformidades Congénitas de la Mano/terapia , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Hibridación Fluorescente in Situ , Discapacidad Intelectual/terapia , Imagen por Resonancia Magnética , Masculino , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Ultrasonografía , Adulto Joven
16.
Vasc Endovascular Surg ; 50(6): 458-9, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27334477

RESUMEN

Right-side aortic arch is a rare congenital aortic anomaly occurring in 0.05% to 0.1% of the general population. Approximately, half of these cases may be associated with an aberrant left subclavian artery and occasionally with aneurysmatic change at its origin known as Kommerell diverticulum or aneurysm (KA). Herein we report a challenging case of a right-side aortic arch associated with KA incidentally observed in a 73-year-old male with metastatic lung cancer. After careful multidisciplinary discussion, a conservative strategy of care was successfully adopted.


Asunto(s)
Aneurisma/terapia , Aorta Torácica/anomalías , Anomalías Cardiovasculares/terapia , Neoplasias del Colon/patología , Trastornos de Deglución/terapia , Neoplasias Pulmonares/secundario , Arteria Subclavia/anomalías , Anciano , Aneurisma/complicaciones , Aneurisma/diagnóstico por imagen , Aorta Torácica/diagnóstico por imagen , Aortografía/métodos , Anomalías Cardiovasculares/complicaciones , Anomalías Cardiovasculares/diagnóstico por imagen , Angiografía por Tomografía Computarizada , Trastornos de Deglución/complicaciones , Trastornos de Deglución/diagnóstico por imagen , Humanos , Hallazgos Incidentales , Neoplasias Pulmonares/diagnóstico por imagen , Masculino , Arteria Subclavia/diagnóstico por imagen , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...